The global cell expansion market was worth around USD 15292.5 million in 2021 and is estimated to grow to about USD 35004.9 million by 2028, with a compound annual growth rate (CAGR) of approximately 14.8 percent over the forecast period.
The global cell expansion market was worth around USD 15292.5million in 2021 and is estimated to grow to about USD 35004.9million by 2028, with a compound annual growth rate (CAGR) of approximately 14.8 percent over the forecast period. The report analyzes the cell expansion market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the cell expansion market.
Cell expansion is a process wherein daughter cell production is done from a single cell in an artificial environment by using culture media and other supplements required for growth. The whole process for the production of daughter cell is carried out in the bioreactor on a large scale. These daughter cells are used for various purposes in the healthcare industry which involves increased usage of regenerative medicines and various other clinical trials. Use of these bioreactors on a large scale is very useful and it reduces the labor and manpower and also reduces the cleaning process on a large scale. The process of cell expansion is mostly used in the development of the new drug, research, and others. It is also widely used for the improved transplantation and treatment of various diseases such as diabetes, arthritis, and others.
The cell expansion market is expected to see a substantial increase in demand as the focus on cell therapies bolsters with rising research and development for the same. The cell expansion market will also be driven by rising investments in the healthcare and pharmaceutical industries to bolster offerings provided by multiple firms operating in the cell expansion market landscape.
Rising research in cell technology, growing demand for personalized medicine, rising focus on healthcare, growing geriatric population, developing healthcare infrastructure, increasing prevalence of chronic diseases, etc. are some major factors that propel cell expansion market potential.
Cell expansion market Increasing Prevalence of Chronic Ailments
Cancer and other chronic diseases have increased in prevalence in recent years and this has bolstered the demand for cell-based therapies and thus propelled the research in cell expansion market. Increasing research will eventually lead to new launches and these are expected to further bolster the cell expansion market growth trend through 2028 and lead the market growth in the changing healthcare landscape.
One of the major factors driving the growth of cell expansion market is increased use of regenerative medicine and chronic medical conditions. To treat those medical conditions and study the effect of developed medicines in the cells has increased the demand for cell expansion. Increased awareness among the people regarding stem cell and its uses have also increased the demand for stem cell preservation which is further expected to drive the growth of cell expansion market over the forecast period. Furthermore, development in the research and development activities coupled with various technological advancements for cell expansion is expected to fuel the growth of cell expansion market over the forecast period. However, the high cost involved in the operation with skilled labor and stringent government regulations for cell expansion process due to the ethical issue are factors expected to hamper the growth of cell expansion market in the near future.
Rising Concerns about Use of Humans and Animals for Cell Research
The cell expansion market is incomplete without cell research and this trend is expected to be the major drives as well as a major restraint to the market due to the ethical concerns associated with it. Use of humans and animals for research has had some pushback from activists across the world and has resulted in slowed research and development activity which constrains the market from attaining full growth. This factor is being worked on to address and change the cell research approach to be more safe and compliant with human and animal rights.
Report Attribute | Details |
---|---|
Base Year | 2020 |
Historic Years | 2016 - 2020 |
Forecast Years | 2021 - 2028 |
Segments Covered | By Product Type, By Application, and By End Use |
Forecast Units | Value (USD Billion), and Volume (Units) |
Quantitative Units | Revenue in USD million/billion and CAGR from 2021 to 2028 |
Regions Covered | North America, Europe, Asia Pacific, Latin America, and MiddleEast & Africa, and Rest of World |
Countries Covered | U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain,China, India, Japan, South Korea, Brazil, Argentina, GCC Countries,and South Africa, among others |
Number of Companies Covered | 10 companies with scope for including additional 15 companies upon request |
Report Coverage | Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis. |
Customization Scope | Avail of customized purchase options to meet your exact research needs. |
The global cell expansion market is segregated based on product,end-user, application, and region.
By End-user, the market is divided into research institutes, consumables, instruments, pharmaceutical & biotechnology companies, consumables, instruments, others, consumables, and instruments. The Biotechnology & biopharmaceutical companies are anticipated to hold a bright outlook over the forecast period and are anticipated to emerge as a major growth driver for the cell expansion market through 2028. The increasing scope of application for healthcare research is anticipated to majorly boost growth in this segment.
By Application, the cell expansion market is segmented into stem cell technology, cancer research, drug screening and development, tissue engineering & regenerative medicine, and others. The regenerative medicine segment is expected to have a highly lucrative growth over the forecast period and is expected to be a significant segment over the forecast period. The stem cell technology segment is also anticipated to rise at a fast CAGR through2028.
North America region leads the global cell expansion market in terms of revenue and volume share and is anticipated to maintain a dominant stance through the forecast period. Increasing focus on healthcare and rising research activities in this region are expected to propel market potential in this region. Increasing awareness about novel treatments, the growing prevalence of the geriatric population, the presence of key cell expansion companies,etc. are some major factors that drive the cell expansion market growth through 2028. The United States is expected to be the most important market in this region over the forecast period.
The market for cell expansion in the Asia Pacific is anticipated to rise at the fastest CAGR over the forecast period. Increasing focus on healthcare is predicted to be a major trend propelling growth in this region. India and China are expected to be the most prominent markets in this region over the forecast period. The increasing geriatric population in Japan is also expected to boost the cell expansion market in this nation.
Some of the main competitors dominating the global cell expansion market include – Becton, Dickinson and Company, CorningIncorporated, Eppendorf, Sartorius AG, Merck KGaA, and Lonza Group AG, PromoCell GmbH, Danaher Corporation, Thermo Fisher Scientific, and HiMedia Laboratories.
The global cell expansion market is segmented as follows:
By Product
By End user
By Application
By Region
FrequentlyAsked Questions
Increasing focus on healthcare and rising investments in research and development activites are some major trends that guide cell expansion market growth.
According to the Zion Market Research report, the global cell expansion market was worth about US$ 15292.5 million in 2021 and is predicted to grow to around US$ 35004.9 million by 2028, with a compound annual growth rate (CAGR) of around 14.8 percent.
The North America region leads the global cell expansion market in terms of revenue and volume share and is anticipated to maintain a dominant stance through the forecast period. Increasing focus on healthcare will be a major trend.
Some of the main competitors dominating the global cell expansion market include -- Becton, Dickinson and Company, Corning Incorporated, Eppendorf, Sartorius AG, Merck KGaA, Lonza Group AG, PromoCell GmbH, Danaher Corporation, Thermo Fisher Scientific, and HiMedia Laboratories.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed